<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109350">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02021864</url>
  </required_header>
  <id_info>
    <org_study_id>hypocalcemia of pregnancy</org_study_id>
    <nct_id>NCT02021864</nct_id>
  </id_info>
  <brief_title>Vitamin D Treatment and Hypocalcemic Pregnant Women</brief_title>
  <official_title>Effect of Treatment of Vitamin D Deficiency During Pregnancy on Hypocalcemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Sima Hashemipour</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sina Hospital, Iran</source>
  <oversight_info>
    <authority>Iran: Ministry of health and medical education.</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Pregnant women in 24-26 gestational week will be recruited.Serum calcium and 25(OH)D
           will be evaluated and women with mild hypocalcemia (serum calcium 8-8.6 mg/dl) and
           25(OH)D less than 30ng/ml will be entered to study. .

        -  Excluding criteria are: gestational diabetes or diabetes before pregnancy, severe
           preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or polyhydramnios,
           parathyroid disorders, hepatic or renal diseases, malnutrition , use of anti-
           convulsive and immunosuppressive drugs.

        -  Participants will randomly assigned in to two groups of intervention and control groups
           .Randomization will be done by random number generator.  Intervention group will
           receive weekly vitamin D3, 50,000 unit for 8 weeks plus daily prenatal multivitamin
           containing elemental calcium 250 mg/day and vitamin D3 400 unit , control group will
           receive daily prenatal multivitamin.

        -  At the time of delivery, serum calcium, 25(OH)D of mothers, maternal weight gain during
           study , Serum calcium and 25(OH)D of newborns and neonatal growth indices ( length,
           weight, head circumference ) will be compared between two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>percentage of hypocalcemic subjects at the ens of study</measure>
    <time_frame>12-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>women in 24-26 weeks of pregnancy will be enrolled.Outcomes will be measured at delivery time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changing of maternal mean calcium level</measure>
    <time_frame>12-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>maternal weight gain</measure>
    <time_frame>12-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>neonatal serum calcium level</measure>
    <time_frame>12-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>neonatal growth indices</measure>
    <time_frame>12-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>neonatal growth indices include neonatal weight, head circumference, length</description>
  </other_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pregnancy Complications</condition>
  <arm_group>
    <arm_group_label>vitamin D3, prenatal multivitamin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vitamin D3 50,000 unit/week for 8 weeks, daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prenatal multivitamin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin D3 50,000 unit</intervention_name>
    <description>vitamin D3 50,000 unit/week for 8 weeks</description>
    <arm_group_label>vitamin D3, prenatal multivitamin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prenatal multivitamin</intervention_name>
    <description>daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit</description>
    <arm_group_label>vitamin D3, prenatal multivitamin</arm_group_label>
    <arm_group_label>prenatal multivitamin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        gestational age of 24-26weeks,mild hypocalcemia (ca=8-8.6mg/dl),singleton pregnancy,  body
        mass index (BMI) of 19-26 -

        Exclusion Criteria:

        moderate  to sever hypocalcemia(ca&lt;8mg/dl),  gestational diabetes or diabetes before
        pregnancy, severe preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or
        polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition , use of
        anti- convulsive and immunosuppressive drugs

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sima Hashemipour, assisstant prefessor</last_name>
    <phone>00989123575592</phone>
    <email>Hashemipour.sima@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Qazvin university of medical science, Kosar hospital</name>
      <address>
        <city>Qazvin</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>shokooh Abotorabi, assistant professor</last_name>
      <phone>00989121822663</phone>
      <email>Abotorabi4242@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>shokooh Abotorabi, assistant professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 19, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sina Hospital, Iran</investigator_affiliation>
    <investigator_full_name>Dr. Sima Hashemipour</investigator_full_name>
    <investigator_title>assistant professor of endocrinology and metabolism</investigator_title>
  </responsible_party>
  <keyword>hypocalcemia, pregnancy, vitamin D</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypocalcemia</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
